Cargando…
Novel Biomarkers for Predicting Preeclampsia
Preeclampsia is a major cause of maternal morbidity and mortality worldwide. Despite decades of research into the condition, the ability of clinicians to predict preeclampsia prior to the onset of symptoms has not improved significantly. In this review, we will examine the pathophysiology underlying...
Autores principales: | Carty, David M., Delles, Christian, Dominiczak, Anna F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishing
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577131/ https://www.ncbi.nlm.nih.gov/pubmed/18790389 http://dx.doi.org/10.1016/j.tcm.2008.07.002 |
Ejemplares similares
-
Impact of preeclampsia on cardiovascular events: An analysis of the Generation Scotland: Scottish family health study
por: Brown, Catriona E., et al.
Publicado: (2023) -
HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia
por: Small, Heather Y., et al.
Publicado: (2017) -
Clinical tools and biomarkers to predict preeclampsia
por: MacDonald, Teresa M, et al.
Publicado: (2021) -
Genetics of hypertension: From experimental animals to humans
por: Delles, Christian, et al.
Publicado: (2010) -
Myeloperoxidase is not a good biomarker for preeclampsia prediction
por: Rocha-Penha, L., et al.
Publicado: (2017)